P170 Long-Term Effectiveness of Omalizumab in Patients With Severe Persistent Allergic (IgE-mediated) Asthma: UK Centre Real-Life Experience

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2013-204457.321
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Long-Term Effectiveness of Omalizumab Treatment in Thai Severe Asthmatic Patients: A Real-Life Experience

Asian Pacific Journal of Allergy and Immunology
MedicineAllergyImmunology
2017English

ABS37: Add-On Omalizumab Improves Asthma Control Across Multiple Measures of Response in Patients With Severe Persistent Allergic (IgE-mediated) Asthma

Primary Care Respiratory Journal
2006English

Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria

Pediatrics
Child HealthPediatricsPerinatology
2017English

Omalizumab in the Treatment of Severe Allergic (IgE-mediated) Asthma: An Update on Recent Developments

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Bronchial Thermoplasty: Long-Term Safety and Effectiveness in Patients With Severe Persistent Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2013English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Long-Term Efficacy and Safety of Omalizumab in Patients With Persistent Uncontrolled Allergic Asthma: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2015English

First Experience With Omalizumab in a Child With Severe Persistent Asthma in Turkey: Case Report

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2010English

Effectiveness of Bronchial Thermoplasty in Severe Asthma in ‘Real Life’ Patients Compared With Those Recruited to Clinical Trials in the Same Centre

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy